Moreover, soluble FasL, a biomarker of ALPS found to be overexpressed in certain SLE patients (32, 33), was measured at high levels in B6/lpr, B6/lpr-p2x7KO, and MRL/lpr sera (Figure 3F). Here, FASLG is linked to autoimmune lymphoproliferative syndrome.